Favorable response of pediatric AIDS‐related Burkitt's lymphoma treated by aggressive chemotherapy

Yoram Neumann, Amos Toren*, Matilda Mandel, Uri Martinowitz, David Varon, Bracha Ramot, Isaac Ben‐Bassat, Gideon Rechavi

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


We describe 4 male children infected by the human immunodeficiency virus (HIV) who developed Burkitt's lymphoma during their disease. The clinical picture was characterized by an insidious appearance of symptoms. All the children suffered for several months from abdominal discomfort and a gradual elevation of their blood lactic dehydrogenase (LDH) level prior to diagnosis. Bone marrow involvement was found in 2 of the patients and jaw involvement in the other 2. After confirming the diagnosis of Burkitt's lymphoma, they were treated according to conventional protocols, with no need to reduce the dose intensity. They all went into complete remission and did not suffer from major opportunistic infections during chemotherapy. None of them relapsed. Two patients died from opportunistic infections 1 and 3 years after diagnosis. The other 2 are alive, 7 years and 6 months after diagnosis. The various characteristics of this unique pediatric group are described and the comparison of the clinical picture in adults is made, together with a review of the relevant literature. © 1993 Wiley‐Liss, Inc.

Original languageEnglish
Pages (from-to)661-664
Number of pages4
JournalMedical and Pediatric Oncology
Issue number9
StatePublished - 1993


  • HIV
  • abdominal discomfort
  • bone marrow
  • children
  • lactic dehydrogenase


Dive into the research topics of 'Favorable response of pediatric AIDS‐related Burkitt's lymphoma treated by aggressive chemotherapy'. Together they form a unique fingerprint.

Cite this